Sort by
Refine Your Search
-
Category
-
Program
-
Field
-
Apply online now: https://karriere.klinikum.uni-heidelberg.de/index.php?ac=application&jobad_id=19226 Postdoc with focus on Single cell multiomics and mass spectrometry in cancer research (m/f/d
-
The research group of Prof. Dr. Michael Mastalerz at the Institute of Organic Chemistry, Heidelberg University is seeking to fill the following temporary positions starting October 1st 2024
-
27 Mar 2024 Job Information Organisation/Company Heidelberg University Research Field All Researcher Profile First Stage Researcher (R1) Country Germany Application Deadline 31 Mar 2024 - 00:00
-
biomedical research hubs in Europe. Our lab uses stem cell technology to study hepatitis E virus (HEV) life cycle and HEV-host interaction. For more details, please visit our website daothilab.com . Job-ID
-
Facility for Flow Cytometry and Cell Sorting (FlowCore Mannheim) headed by Prof. Dr. Karen Bieback at the Core Facility Platform Mannheim, Medical Faculty Mannheim, Heidelberg University is offering a
-
. This project involves work on patient-derived renal organoids to decipher molecular signatures and develop therapeutic interventions that can modify the disturbed signaling pathways and cell functions. Job-ID
-
of marine larvae and sensory cell types”. This Project is part of The Marie Sklodowska-Curie Doctoral Network: "ZooCELL: Tracing the evolution of sensory cell types in animal diversity: multidisciplinary
-
-omics data including genomics, transcriptomics, epigenomics, and proteomics, with a focus on microbiome analysis (metagenomics), single-cell sequencing, and spatial analysis for cancer research. Develop
-
B cell lymphoma (DLBCL). We aim to decode epigenetic principles of disease, in particular targeting enhancers and other regulatory elements. The final aim of our studies is to translate
-
cancer cells (Hon et al., 2012, Esteller et al., 2007). Alternative promoter usage in cancer can lead to the formation of tumor specific antigens, which can furthermore be used as therapeutic targets (Shah